M. Wolff

发表

A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts

R. Hogg, K. Buchacz, T. Sterling, 2016, Journal of the International AIDS Society.

Mortality and loss to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean

P. Cahn, V. Fink, J. Pape, 2015, Journal of the International AIDS Society.

Maraviroc, as a Switch Option, in HIV-1-infected Individuals With Stable, Well-controlled HIV Replication and R5-tropic Virus on Their First Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Plus Ritonavir-boosted Protease Inhibitor Regimen: Week 48 Results of the Randomized, Multicenter MARCH S

R. Kaiser, J. Gatell, K. Ruxrungtham, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey

T. Weitzel, X. Aguilera, C. Cortés, 2020, PloS one.

Efficacy and safety of emtricitabine vs stavudine in combination therapy in antiretroviral-naive patients: a randomized trial.

M. Saag, P. Cahn, W. Powderly, 2004, JAMA.

Cohort Profile: Caribbean, Central and South America Network for HIV research (CCASAnet) collaboration within the International Epidemiologic Databases to Evaluate AIDS (IeDEA) programme.

D. Masys, P. Cahn, J. Pape, 2007, International journal of epidemiology.

Pneumonia in HIV-infected persons: increased risk with cigarette smoking and treatment interruption.

P. Easterbrook, J. Lundgren, M. Roediger, 2008, American journal of respiratory and critical care medicine.

[Accidental exposure to health care workers of blood and body fluids from patients].

M. Wolff, S. Hidalgo, 1992, Revista medica de Chile.

HIV Drug Therapy in the Americas 16–18 April 2015, Mexico City, Mexico

M. Lederman, D. Podzamczer, D. Kuritzkes, 2015, Journal of the International AIDS Society.

Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

Sally S Bebawy, Richard D Moore, J. Margolick, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Time to HAART Initiation after Diagnosis and Treatment of Opportunistic Infections in Patients with AIDS in Latin America

V. Fink, B. Grinsztejn, B. Shepherd, 2016, PloS one.

A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy

P. Cahn, J. Pape, E. Gotuzzo, 2017, PloS one.

Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy

W. Wester, T. Sterling, P. Cahn, 2022, BMC Infectious Diseases.

Hepatitis B prevalence and influence on HIV treatment outcome and mortality in the Chilean AIDS Cohort.

T. Weitzel, R. Otto-Knapp, C. Cortés, 2013, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

[First isolation of KPC in Chile: from Italy to a public hospital in Santiago].

M. Cifuentes, Francisco Silva, M. Wolff, 2012, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

Long-Term Outcomes of a National Expanded Access Program to Antiretroviral Therapy: The Chilean AIDS Cohort

B. Shepherd, C. Cortés, M. Wolff, 2010, Journal of acquired immune deficiency syndromes.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

[Outbreak of acute histoplasmosis in Chilean travelers to the ecuadorian jungle: an example of geographic medicine].

M. Wolff, 1999, Revista medica de Chile.

The prevalence and aetiology of persistent diarrhoea in adults in urban Zambia.

M. Farthing, N. Luo, M. Wolff, 1996, Acta tropica.

Isolation and characterization of a novel insect defensin from Rhodnius prolixus, a vector of Chagas disease.

C. Lowenberger, M. Wolff, L. López, 2003, Insect biochemistry and molecular biology.

[Occupational accidents with exposure to biological fluids. Recommendations for the management of exposed workers].

M. Wolff, 1997, Revista medica de Chile.

Efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV-infected, antiretroviral-naive adults (ENCORE1): a randomised, double-blind, placebo-controlled, non-inferiority trial

B. Gazzard, D. Cooper, P. Phanuphak, 2014, The Lancet.

Rates and Reasons for Early Change of First HAART in HIV-1-Infected Patients in 7 Sites throughout the Caribbean and Latin America

D. Masys, P. Cahn, V. Fink, 2010, PloS one.

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.

K. Ruxrungtham, D. Cooper, H. Teppler, 2015, The lancet. HIV.

Use and misuse of antibiotics in Latin America.

M. Wolff, Marcelo Wolff, 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[Clinical and epidemiological characteristics of HIV infection in Latin-American immigrants: comparative analysis from clinical records in a clinical care centre in Santiago in the last decade].

C. Cortés, M. Wolff, M. F. Rodríguez, 2015, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

Clinical and Virologic Outcomes After Changes in First Antiretroviral Regimen at 7 Sites in the Caribbean, Central and South America Network

P. Rebeiro, J. Pape, B. Shepherd, 2016, Journal of acquired immune deficiency syndromes.

Role and effects of zinc supplementation in HIV-infected patients with immunovirological discordance: A randomized, double blind, case control study

M. Wolff, A. Canals, M. J. Mackenna, 2021, PloS one.

Immunodeficiency at the Start of Combination Antiretroviral Therapy in Low-, Middle-, and High-Income Countries

B. Chi, J. Sterne, K. Anastos, 2013, Journal of acquired immune deficiency syndromes.

Monitoring of HIV treatment in seven countries in the WHO Region of the Americas

P. Cahn, J. Pape, E. Gotuzzo, 2015, Bulletin of the World Health Organization.

Clinical and virologic outcomes after changing first antiretroviral regimen at 7 sites in the Caribbean, Central, and South America Network (CCASAnet)

J. Pape, E. Gotuzzo, B. Grinsztejn, 2013 .

Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America

J. Pape, B. Shepherd, B. Crabtree-Ramírez, 2020, PloS one.

The Chilean AIDS Cohort: A Model for Evaluating the Impact of an Expanded Access Program to Antiretroviral Therapy in a Middle-Income Country-Organization and Preliminary Results

M. Wolff, Patricia Vásquez, C. Beltrán, 2005, Journal of acquired immune deficiency syndromes.

Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean

D. Masys, P. Cahn, J. Pape, 2009, Journal of acquired immune deficiency syndromes.

[Efectiveness and safety of switching to raltegravir-based regimen in dyslipidemic HIV-infected patients receiving antiretroviral therapy at Arriaran Foundation].

M. Wolff, Desiree D. Vera, Renato J. Ocampo, 2019, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

Clinical Outcomes in Hospitalized Vaccine-Breakthrough Coronavirus Disease 2019 Cases Compared With Contemporary Unvaccinated Hospitalized Adults

M. Wolff, Margarita Gilabert, R. Hernández, 2022, Open forum infectious diseases.

Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America

Richard D Moore, J. Willig, T. Sterling, 2016, Journal of the International AIDS Society.

Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: a growing challenge

B. Grinsztejn, B. Shepherd, B. Crabtree-Ramírez, 2018, Epidemiology and Infection.

Durability of Efavirenz Compared With Boosted Protease Inhibitor-Based Regimens in Antiretroviral-Naïve Patients in the Caribbean and Central and South America

J. Pape, E. Gotuzzo, B. Grinsztejn, 2018, Open forum infectious diseases.

[Virological evolution of patients with HIV infection that start antiretroviral therapy with a very high baseline viral load].

C. Cortés, M. Wolff, Humberto Villalobos, 2021, Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia.

Evaluating the care cascade after antiretroviral therapy initiation in Latin America

P. Rebeiro, B. Grinsztejn, C. Cortés, 2018, International journal of STD & AIDS.

Long-Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection.

R. Paredes, H. Furrer, A. Phillips, 2023, NEJM evidence.

[Antiretroviral therapy. Announcement of the Advisory Committee of the Chilean Society of Infectology on AIDS].

G. Acuña, O. Morales, M. Wolff, 1998, Revista médica de Chile (Impresa).

Detection and management of drug-resistant tuberculosis in HIV-infected patients in lower-income countries.

G. Gottlieb, J. Stringer, C. Yiannoutsos, 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Implementation of “Treat‐all” at adult HIV care and treatment sites in the Global IeDEA Consortium: results from the Site Assessment Survey

Victor C. M. Leung, L. C. Medina, David J. Smith, 2019, Journal of the International AIDS Society.

Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.

K. Ruxrungtham, D. Cooper, H. Teppler, 2015, The lancet. HIV.